Bank of New York Mellon Corp - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$323,896
-57.0%
128,022
+13.2%
0.00%
Q2 2023$753,386
-47.7%
113,121
+46.7%
0.00%
Q1 2023$1,439,283
-6.9%
77,132
+7.2%
0.00%
Q4 2022$1,545,465
+100.4%
71,949
+10.3%
0.00%
Q3 2022$771,000
-3.9%
65,219
+7.3%
0.00%
Q2 2022$802,000
-34.3%
60,809
+4.1%
0.00%
Q1 2022$1,220,000
+5.7%
58,386
+2.9%
0.00%
Q4 2021$1,154,000
-29.8%
56,749
+4.8%
0.00%
Q3 2021$1,645,000
+14.0%
54,171
+9.1%
0.00%
Q2 2021$1,443,000
-44.7%
49,669
-17.9%
0.00%
-100.0%
Q1 2021$2,609,000
-8.6%
60,484
-2.2%
0.00%0.0%
Q4 2020$2,856,000
+18.5%
61,820
+11.2%
0.00%0.0%
Q3 2020$2,410,000
-13.3%
55,597
+6.0%
0.00%0.0%
Q2 2020$2,780,000
+149.3%
52,453
+5.2%
0.00%
Q1 2020$1,115,000
+292.6%
49,854
+156.7%
0.00%
Q4 2019$284,000
+107.3%
19,4230.0%0.00%
Q3 2019$137,000
-30.8%
19,423
+7.4%
0.00%
Q2 2019$198,00018,0830.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 40,000$836,0001.01%
ACT CAPITAL MANAGEMENT, LLC 20,000$418,0000.44%
Knoll Capital Management, LLC 20,000$418,0000.26%
Artemis Investment Management LLP 1,428,228$29,855,0000.24%
Rubric Capital Management LP 268,528$5,615,0000.20%
Virtus ETF Advisers LLC 7,713$161,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 107,700$2,252,0000.05%
PDT Partners, LLC 28,031$586,0000.05%
AllSquare Wealth Management LLC 3,162$66,0000.04%
Hennion & Walsh Asset Management, Inc. 35,221$736,0000.04%
View complete list of BIOXCEL THERAPEUTICS INC shareholders